Cancer Immunology Immunotherapy

译名:癌症免疫学与免疫治疗

CANCER IMMUNOLOGY IMMUNOTHERAPY

SCIEJCR Q1

5-10

2026

影响因子区间

平台估算

投稿周期

55%

2025

中国作者发文占比

费用说明

收费

期刊简介:Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology. As knowledge expands, the scope of the journal has broadened to include more of the progress being made in the areas of biology concerned with biological response modifiers. This helps keep readers up to date on the latest advances in our understanding of tumor-host interactions.The journal publishes short editorials including "position papers," general reviews, original articles, and short communications, providing a forum for the most current experimental and clinical advances in tumor immunology.

【译文】癌症免疫学和免疫治疗杂志的基本目的是让读者了解肿瘤学和免疫学领域的最新研究成果。随着知识的扩展,该杂志的范围已经扩大,包括与生物反应调节剂相关的生物学领域的更多进展。这有助于读者了解我们对肿瘤-宿主相互作用理解的最新进展。该杂志发表包括‘立场论文’在内的简短社论、综述、原创文章和简报,为肿瘤免疫学中最新的实验和临床进展提供一个论坛。

出版社
Springer Science+Business Media
语言
English
学科
医学
ISSN
0340-7004
eISSN
1432-0851
出版频率
月刊
创刊年份
1976
投稿网址
https://www.editorialmanager.com/ciim
最近更新
2026-04-02 18:16:40
Cancer Immunology Immunotherapy

指标当前值近三年趋势
JCR分区Q1
暂无
影响因子区间5-10
暂无